642 related articles for article (PubMed ID: 19167974)
1. Pelvic exenteration for clinical T4 rectal cancer: oncologic outcome in 93 patients at a single institution over a 30-year period.
Ishiguro S; Akasu T; Fujita S; Yamamoto S; Kusters M; Moriya Y
Surgery; 2009 Feb; 145(2):189-95. PubMed ID: 19167974
[TBL] [Abstract][Full Text] [Related]
2. Indication and benefit of pelvic sidewall dissection for rectal cancer.
Sugihara K; Kobayashi H; Kato T; Mori T; Mochizuki H; Kameoka S; Shirouzu K; Muto T
Dis Colon Rectum; 2006 Nov; 49(11):1663-72. PubMed ID: 17041749
[TBL] [Abstract][Full Text] [Related]
3. Outcome of total pelvic exenteration for locally recurrent rectal cancer.
Ike H; Shimada H; Ohki S; Yamaguchi S; Ichikawa Y; Fujii S
Hepatogastroenterology; 2003; 50(51):700-3. PubMed ID: 12828064
[TBL] [Abstract][Full Text] [Related]
4. Efforts to improve local control in rectal cancer compromise survival by the potential morbidity of optimal mesorectal excision.
Laurent C; Nobili S; Rullier A; Vendrely V; Saric J; Rullier E
J Am Coll Surg; 2006 Nov; 203(5):684-91. PubMed ID: 17084330
[TBL] [Abstract][Full Text] [Related]
5. Comparative outcome between chemoradiotherapy and lateral pelvic lymph node dissection following total mesorectal excision in rectal cancer.
Kim JC; Takahashi K; Yu CS; Kim HC; Kim TW; Ryu MH; Kim JH; Mori T
Ann Surg; 2007 Nov; 246(5):754-62. PubMed ID: 17968166
[TBL] [Abstract][Full Text] [Related]
6. Surgical strategy for local recurrence after resection of rectal cancer.
Fujii S; Shimada H; Yamagishi S; Ota M; Ichikawa Y; Kunisaki C; Ike H; Ohki S
Hepatogastroenterology; 2009; 56(91-92):667-71. PubMed ID: 19621677
[TBL] [Abstract][Full Text] [Related]
7. Posterior pelvic exenteration for primary rectal cancer.
Bannura GC; Barrera AE; Cumsille MA; Contreras JP; Melo CL; Soto DC; Mansilla JE
Colorectal Dis; 2006 May; 8(4):309-13. PubMed ID: 16630235
[TBL] [Abstract][Full Text] [Related]
8. Surgical salvage of recurrent rectal cancer after transanal excision.
Weiser MR; Landmann RG; Wong WD; Shia J; Guillem JG; Temple LK; Minsky BD; Cohen AM; Paty PB
Dis Colon Rectum; 2005 Jun; 48(6):1169-75. PubMed ID: 15793645
[TBL] [Abstract][Full Text] [Related]
9. Sacral resection for recurrent rectal cancer: analysis of morbidity and treatment results.
Melton GB; Paty PB; Boland PJ; Healey JH; Savatta SG; Casas-Ganem JE; Guillem JG; Weiser MR; Cohen AM; Minsky BD; Wong WD; Temple LK
Dis Colon Rectum; 2006 Aug; 49(8):1099-107. PubMed ID: 16779712
[TBL] [Abstract][Full Text] [Related]
10. Effect of adjuvant radiotherapy on local recurrence in stage II rectal cancer.
Park IJ; Kim HC; Yu CS; Kim TW; Jang SJ; Kim JC
Ann Surg Oncol; 2008 Feb; 15(2):519-25. PubMed ID: 17960464
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of surgery alone for lower rectal cancer with and without pelvic sidewall dissection.
Kobayashi H; Mochizuki H; Kato T; Mori T; Kameoka S; Shirouzu K; Sugihara K
Dis Colon Rectum; 2009 Apr; 52(4):567-76. PubMed ID: 19404054
[TBL] [Abstract][Full Text] [Related]
12. Chemoradiotherapy followed by surgery in rectal cancer: improved local control using a moderately high pelvic radiation dose.
Lee SH; Lee KC; Choi JH; Oh JH; Baek JH; Park SH; Shin DB
Jpn J Clin Oncol; 2008 Feb; 38(2):112-21. PubMed ID: 18263881
[TBL] [Abstract][Full Text] [Related]
13. Patterns of pelvic invasion are prognostic in the treatment of locally recurrent rectal cancer.
Yamada K; Ishizawa T; Niwa K; Chuman Y; Akiba S; Aikou T
Br J Surg; 2001 Jul; 88(7):988-93. PubMed ID: 11442533
[TBL] [Abstract][Full Text] [Related]
14. Mesorectal lymph node involvement and prognostic implications at total pelvic exenteration for gynecologic malignancies.
Mourton SM; Chi DS; Sonoda Y; Alektiar KM; Venkatraman ES; Barakat RR; Abu-Rustum NR
Gynecol Oncol; 2006 Mar; 100(3):533-6. PubMed ID: 16226800
[TBL] [Abstract][Full Text] [Related]
15. [Conservative surgery in the treatment of rectal tumors. Our experience, 1986-1997].
Cerroni M; Droghetti A; Avenia N; Palumbo M; Marianeschi PM; Daddi G
Ann Ital Chir; 1999; 70(3):435-40; discussion 440-1. PubMed ID: 10466247
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcome of anastomosis leakage after curative resection for mid and low rectal cancer.
Chang SC; Lin JK; Yang SH; Jiang JK; Chen WC; Lin TC
Hepatogastroenterology; 2003; 50(54):1898-902. PubMed ID: 14696429
[TBL] [Abstract][Full Text] [Related]
17. Intersphincteric resection for very low rectal adenocarcinoma: univariate and multivariate analyses of risk factors for recurrence.
Akasu T; Takawa M; Yamamoto S; Ishiguro S; Yamaguchi T; Fujita S; Moriya Y; Nakanishi Y
Ann Surg Oncol; 2008 Oct; 15(10):2668-76. PubMed ID: 18618181
[TBL] [Abstract][Full Text] [Related]
18. Outcome of anterior resection for stage II rectal cancer without radiation: the role of adjuvant chemotherapy.
Law WL; Ho JW; Chan R; Au G; Chu KW
Dis Colon Rectum; 2005 Feb; 48(2):218-26. PubMed ID: 15711860
[TBL] [Abstract][Full Text] [Related]
19. Indications for primary and secondary exenterations in patients with cervical cancer.
Marnitz S; Köhler C; Müller M; Behrens K; Hasenbein K; Schneider A
Gynecol Oncol; 2006 Dec; 103(3):1023-30. PubMed ID: 16890276
[TBL] [Abstract][Full Text] [Related]
20. Surgery for locally recurrent rectal cancer.
Boyle KM; Sagar PM; Chalmers AG; Sebag-Montefiore D; Cairns A; Eardley I
Dis Colon Rectum; 2005 May; 48(5):929-37. PubMed ID: 15785880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]